Table 3.
r | R 2 | Beta | p | |
---|---|---|---|---|
Age | 0.135 | 0.0182 | 0.135 | 0.153 |
Disease duration | 0.443 | 0.1963 | 0.443 | <0.001 ** |
MDS-UPDRS II | 0.788 | 0.6209 | 0.788 | <0.001 ** |
BDI | 0.700 | 0.4900 | 0.700 | <0.001 ** |
TAS-26 | 0.472 | 0.2228 | 0.472 | <0.001 ** |
TAS-26 F1 | 0.557 | 0.3103 | 0.557 | <0.001 ** |
TAS-26 F2 | 0.302 | 0.0912 | 0.302 | 0.001 ** |
TAS-26 F3 | 0.135 | 0.0182 | 0.135 | 0.162 |
Linear regression analysis of factors contributing to patients’ health-related quality of life. p-value adjustment for multiple comparisons was 0.05/8. ** indicate significance level at p < 0.006 printed in bold. Abbreviations: BDI, Beck depression inventory; MDS-UPDRS, Movement Disorders Society unified Parkinson’s disease rating scale; PD, Parkinson’s disease; PDQ-8, Parkinson’s disease questionnaire 8; TAS-26, Toronto alexithymia scale 26 (F1: difficulties identifying feelings, F2: difficulties describing feelings, and F3: external oriented thinking).